Title : PROCLAIM: pilot study to examine the effects of clopidogrel on inflammatory markers in patients with metabolic syndrome receiving low-dose aspirin.

Pub. Date : 2009

PMID : 20069077






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 There was a significant difference at Week 6 in model-adjusted CD40-ligand levels in favor of clopidogrel plus aspirin compared with placebo plus aspirin in both the intent-to-treat population (difference between least-squares means = -186.5; 95% confidence interval, -342.3 to -30.8; P = 0.02) and the per-protocol population (P = 0.05). Clopidogrel CD40 ligand Homo sapiens
2 Data from this study suggest that clopidogrel can decrease the expression of the CD40-ligand biomarker. Clopidogrel CD40 ligand Homo sapiens